STOCK TITAN

Taitron Compnent 8-K Filings

TAIT OTC Link

Every 8-K that Taitron Compnent (TAIT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow TAIT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TAIT filings page.

Rhea-AI Summary

Taitron Components Incorporated announced a voluntary delisting of its Class A common stock from the Nasdaq Capital Market and plans to deregister its shares under the Exchange Act based on having fewer than 300 holders of record. The board determined the ongoing costs and resource demands of a Nasdaq listing and SEC reporting outweigh the benefits.

The company expects to file Form 25 on or about November 24, 2025, with the delisting effective on or about December 4, 2025, after which Nasdaq trading will cease. Shares may be eligible for quotation on the OTC Markets’ Pink tier if market makers participate, but there is no assurance. Taitron then plans to file Form 15 on or about December 8, 2025, suspending periodic reporting immediately and terminating Exchange Act registration 90 days thereafter.

Separately, on November 10, 2025, David Vanderhorst resigned as Chief Financial Officer and Secretary and will continue as Controller. CEO Stewart Wang assumed principal financial officer and principal accounting officer duties.

Rhea-AI Summary

Taitron Components (TAIT) declared a quarterly cash dividend of $0.035 per share on its Class A and Class B common stock. The dividend is payable on November 26, 2025 to stockholders of record as of November 14, 2025.

The company’s current dividend policy targets $0.14 per share per year, paid in equal quarterly installments of $0.035 per share. Future dividends, record dates, and payment dates remain subject to the Board’s ongoing determination of the policy’s suitability and may be suspended or canceled at any time.